Source comparison
MOTS-c with Alcohol Safety: Full Comparison
AMPK Activation Increases AMPK phosphorylation by 50–70% in preclinical models Reduces AMPK activity by 30–40% during metabolism Partial antagonism. Peptide effect blunted but not eliminated Avoid co-administration within 6–8 hours to preserve AMPK signaling M
This comparison does not assign a generated winner or score.
- AMPK Activation
- Increases AMPK phosphorylation by 50–70% in preclinical models
- Reduces AMPK activity by 30–40% during metabolism
- Partial antagonism. Peptide effect blunted but not eliminated
- Avoid co-administration within 6–8 hours to preserve AMPK signaling
- Mitochondrial Biogenesis
- Upregulates PGC-1α, increases mitochondrial density
- Impairs mitochondrial membrane integrity, reduces ATP synthesis by 25–35%
- Functional conflict. Alcohol undermines the pathway MOTS-c supports
- Chronic alcohol use likely negates long-term MOTS-c benefits
- NAD+ Metabolism
- Enhances NAD+ biosynthesis via AMPK-mediated pathway activation
- Depletes NAD+ through ADH/ALDH metabolism of ethanol
- Substrate-level competition. Both processes demand NAD+
- Moderate-to-heavy drinking creates NAD+ scarcity that limits peptide efficacy
- Oxidative Stress
- Increases SOD2 and catalase expression, enhances antioxidant capacity by 30–40%
- Generates superoxide and hydrogen peroxide, increases ROS by 50%+
- Antioxidant defenses overwhelmed if oxidative load exceeds capacity
- Single acute intake tolerable; chronic intake negates antioxidant gains
- Insulin Sensitivity
- Improves glucose uptake and insulin signaling in skeletal muscle
- Induces transient insulin resistance through inflammatory cytokine release
- Short-term insulin resistance from alcohol opposes MOTS-c's metabolic benefits
- Timing-dependent. Acute alcohol after MOTS-c administration reduces glucose uptake improvements
- Inflammatory Response
- Reduces TNF-α and IL-6 in preclinical aging models
- Increases TNF-α by 50–70% via acetaldehyde-protein adduct formation
- Inflammatory environment counters anti-inflammatory effects of peptide
- Chronic inflammation from alcohol prevents MOTS-c from achieving baseline reductions